| Item | Cat. No. | Application | Isotype |
| Anti-CD39 mAbs [CAT 13.9B4](MABL-914) | MABL-914 | Engineer antibody | |
| Anti-CD39 mAbs [I-391](MABL-915) | MABL-915 | neutralize, ELISA, FC | Engineer antibody |
| Anti-CD39 mAbs [I-392](MABL-916) | MABL-916 | neutralize, ELISA, FC | Engineer antibody |
| Anti-CD39 mAbs [mAb2](MABL-917) | MABL-917 | inhibition, ELISA, FC | Engineer antibody |
| Anti-CD3e mAbs [33H1](MABL-918) | MABL-918 | WB, ELISA, IHC | Engineer antibody |
| Anti-CD3e mAbs [898H2-6-15](MABL-919) | MABL-919 | FC, IHC | Engineer antibody |
| Anti-CD3e mAbs [PC3/188A](MABL-920) | MABL-920 | WB, IHC | Engineer antibody |
| Anti-CD3e mAbs [Visilizumab (HuM291)](MABL-921) | MABL-921 | immunesuppression, therapeutic, FC | Engineer antibody |
| Anti-CD4 mAbs [OX-68](MABL-922) | MABL-922 | binding assay, IP, SPR, WB, FC | Engineer antibody |
| Anti-CD4 mAbs [13B8.2 (IOT4a)](MABL-923) | MABL-923 | EIA, WB, ELISA, FC, IHC-Fr | Engineer antibody |
| Anti-CD4 mAbs [3F11](MABL-924) | MABL-924 | Blocking, FACS, ELISA | Engineer antibody |
| Anti-CD4 mAbs [6G5 (Zanolimumab)](MABL-925) | MABL-925 | ELISA, FC, Inhibit, | Engineer antibody |
| Anti-CD4 mAbs [8A5](MABL-926) | MABL-926 | WB, ELISA, IF | Engineer antibody |
| Anti-CD4 mAbs [DB81](MABL-927) | MABL-927 | neutralising, ELISA, FC | Engineer antibody |
| Anti-CD4 mAbs [GK1.5](MABL-928) | MABL-928 | functional assay, ELISA, FC, IF, IHC | Engineer antibody |
| Anti-CD4 mAbs [OKT4A](MABL-929) | MABL-929 | functional assay, treatment;, FC, IF, IHC | Engineer antibody |
| Anti-CD4 mAbs [OX-35](MABL-930) | MABL-930 | functional, IP, WB, ELISA, IF, IHC | Engineer antibody |
| Anti-CD4 mAbs [OX-38](MABL-931) | MABL-931 | IP, FC | Engineer antibody |
| Anti-CD4 mAbs [W3/25](MABL-932) | MABL-932 | FC, IHC | Engineer antibody |
| Anti-CD4 mAbs [YKIX302.9](MABL-933) | MABL-933 | FC, IHC, IHC-Fr | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
